Detalhe da pesquisa
1.
Regulatory and Clinical Experiences with Biosimilar Filgrastim in the U.S., the European Union, Japan, and Canada.
Oncologist
; 24(4): 537-548, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30842244
2.
Generic oncology drugs: are they all safe?
Lancet Oncol
; 17(11): e493-e501, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27819247
3.
Comparative Risk of Anaphylactic Reactions Associated With Intravenous Iron Products.
JAMA
; 314(19): 2062-8, 2015 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-26575062
4.
Pain palliation measurement in cancer clinical trials: the US Food and Drug Administration perspective.
Cancer
; 120(5): 761-7, 2014 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24375398
5.
Cardiac imaging approaches to evaluate drug-induced myocardial dysfunction.
Am Heart J
; 164(6): 846-55, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23194484
6.
Routine Iron Supplementation and Screening for Iron Deficiency Anemia in Pregnancy.
Ann Intern Med
; 163(5): 399-400, 2015 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26322707
7.
Sorafenib for the treatment of unresectable hepatocellular carcinoma.
Oncologist
; 14(1): 95-100, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19144678
8.
The clinical significance of statistical significance.
Oncologist
; 13(11): 1129-33, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18984874
9.
Comparative effectiveness and health care spending.
N Engl J Med
; 362(19): 1845-6, 2010 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-20463349
10.
Bortezomib for the treatment of mantle cell lymphoma.
Clin Cancer Res
; 13(18 Pt 1): 5291-4, 2007 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17875757
11.
United States Food and Drug Administration approval summary: bortezomib for the treatment of progressive multiple myeloma after one prior therapy.
Clin Cancer Res
; 12(10): 2955-60, 2006 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16707588
12.
Sorafenib for the treatment of advanced renal cell carcinoma.
Clin Cancer Res
; 12(24): 7271-8, 2006 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17189398
13.
Interpretability of Cancer Clinical Trial Results Using Restricted Mean Survival Time as an Alternative to the Hazard Ratio.
JAMA Oncol
; 3(12): 1692-1696, 2017 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28975263
14.
Melanoma complicating treatment with natalizumab for multiple sclerosis: A report from the Southern Network on Adverse Reactions (SONAR).
Cancer Med
; 6(7): 1541-1551, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28635055
15.
FDA Approval: Blinatumomab.
Clin Cancer Res
; 21(18): 4035-9, 2015 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26374073
16.
FDA approval: idelalisib monotherapy for the treatment of patients with follicular lymphoma and small lymphocytic lymphoma.
Clin Cancer Res
; 21(7): 1525-9, 2015 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25645861
17.
FDA Approval: Ibrutinib for Patients with Previously Treated Mantle Cell Lymphoma and Previously Treated Chronic Lymphocytic Leukemia.
Clin Cancer Res
; 21(16): 3586-90, 2015 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26275952
18.
FDA Approval: Belinostat for the Treatment of Patients with Relapsed or Refractory Peripheral T-cell Lymphoma.
Clin Cancer Res
; 21(12): 2666-70, 2015 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25802282
19.
A possible association between fetal/neonatal exposure to radiofrequency electromagnetic radiation and the increased incidence of autism spectrum disorders (ASD).
Med Hypotheses
; 62(2): 195-7, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-14962625
20.
Intravenous iron replacement with sodium ferric gluconate complex in sucrose for iron deficiency anemia in adults.
Curr Ther Res Clin Exp
; 64(4): 263-8, 2003 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24944373